SN
Shailesh Narottambhai Chauhan
About Shailesh Narottambhai Chauhan
Data last updated:
Shailesh Narottambhai Chauhan has 14 years in corporate governance. Holds Director role. Currently with 1 company, including Invasion Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Invasion Pharmaceuticals Private Limited at ₹1.62 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Oct 2011 | 2011 | ₹1.62 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shailesh Narottambhai Chauhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shailesh Narottambhai Chauhan
Shailesh Narottambhai Chauhan has 14 years in corporate governance. Holds Director role. Currently with 1 company, including Invasion Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Invasion Pharmaceuticals Private Limited at ₹1.62 Cr (FY 2025).
Shailesh Narottambhai Chauhan is associated with 1 company as Director, including Invasion Pharmaceuticals Private Limited (₹1.62 Cr).
Shailesh Narottambhai Chauhan has expertise in General Business.
Shailesh Narottambhai Chauhan has 14 years in corporate governance.
By reported revenue, the largest current company of Shailesh Narottambhai Chauhan is Invasion Pharmaceuticals Private Limited, with revenue of ₹1.62 Cr (FY 2025).
Shailesh Narottambhai Chauhan currently holds positions at 1 company: Invasion Pharmaceuticals Private Limited (₹1.62 Cr).